BALYASNY ASSET MANAGEMENT L.P. - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 62 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$208,612
+293.6%
17,341
+49.1%
0.00%
Q2 2022$53,000
-82.9%
11,627
-46.4%
0.00%
-100.0%
Q4 2021$310,00021,6870.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 366,401$2,374,0002.07%
Private Portfolio Partners LLC 67,400$436,7520.12%
Knoll Capital Management, LLC 20,000$130,0000.08%
ETF MANAGERS GROUP, LLC 94,493$612,0000.02%
Virtu Financial LLC 21,526$139,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 21,904$142,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$36,0000.01%
Walleye Capital LLC 78,418$508,0000.01%
Jump Financial, LLC 36,100$234,0000.01%
Plante Moran Financial Advisors, LLC 7,911$51,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders